Search Results

240 results for bmti

3 Blue-Chip Stocks to Buy at 52-Week Lows in May

By Viktor Zarev, InvestorPlace Contributor

These three blue-chip stocks at a 52-week low could provide investors with a good opportunity to open a new position or double an old one.

7 Stocks Primed for a Spectacular Comeback in 2024

By Josh Enomoto, InvestorPlace Contributor

Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields

By Alex Sirois, InvestorPlace Contributor

Investing in high-yield dividend stocks under $50 is a low-risk strategy that can result in massive returns in time.

Buy Alert: 3 Penny Stocks That Will Explode in 2024

By Viktor Zarev, InvestorPlace Contributor

7 Underappreciated Stocks With 25% Return Potential in 2024

By Alex Sirois, InvestorPlace Contributor

Each of these underappreciated stocks is expected to provide 25%+ returns this year, which is reason enough to pay attention.

7 Stocks That Could Safely 10X by 2030

By Omor Ibne Ehsan

Unlock the potential for exponential growth with these seven 10x stocks that could skyrocket by 2030 if the stars align.

6 Biotech Stocks to Buy Now Ahead of These June Catalysts

By Shanthi Rexaline

Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a…

7 Safe-Haven Stocks to Weather Any Storm

By Yiannis Zourmpanos, InvestorPlace Contributor

Explore top safe-haven stocks to buy now for stability and consistent growth during economic turbulence and uncertainty.

BMTX Stock Earnings: BM Technologies Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

BMTX stock results show that BM Technologies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

3 Bargain Stocks to Buy Now: May 2024

By Charles Munyi, InvestorPlace Contributor

These bargain stocks to buy provide substantial upside since they are trading at a significant discount to their historical multiples.

RMTI Stock Earnings: Rockwell Medical Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

RMTI stock results show that Rockwell Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Palomar Medical Technologies (PMTI) Reinventing the Fountain of Youth

By Jamie Dlugosch, InvestorPlace Writer

Remember that song by Carly Simon, “You’re So Vain?” I heard it on the radio the other day and thought it would be good song…

BKTI Stock Earnings: BK Technologies Reported Results for Q1 2024

By InvestorPlace Earnings

BK Technologies just reported results for the first quarter of 2024.

7 Dividend Stocks to Buy on the Dip: May 2024

By Marc Guberti, InvestorPlace Contributor

Investors looking for the top dividend stocks to buy should start with some of these compelling opportunities.

3 High-Yield Dividend Stocks to Secure Your Financial Future

By Yiannis Zourmpanos, InvestorPlace Contributor

Explore the best high-yield dividend stocks for portfolio stability and robust financial growth in dynamic markets.

BITI ETF: 10 Things to Know About the New ProShares Short Bitcoin ETF

By William White, InvestorPlace Writer

Investors wondering how to short Bitcoin (BTC) are gaining a new option with the ProShares Short Bitcoin Strategy ETF (BITI).

Bristol-Myers Squibb Co’s (BMY) Solid Quant Score Keeps it a Buy

By Portfolio Grader

The current recommendation of Buy for Bristol-Myers Squibb Co (NYSE:BMY) is derived using Louis Navellier’s approach to investing and his Portfolio Grader stock evaluator. BMY…

Should I Buy Bristol-Myers Squibb? 3 Pros, 3 Cons

By Tom Taulli, InvestorPlace Contributor

Its deal to buy diabetes-drug maker Amylin will help, given that market’s potential. Still, patent expirations loom large and won’t be easily overcome.

Bristol-Myers Squibb Co (BMY) Ranking Raised to Buy on Superior Earnings Visibility

By Portfolio Grader

Bristol-Myers Squibb Co (NYSE:BMY) is a constituent of the 135 company Pharmaceuticals GICS industry group, which is part of the 783 company GICS Health Care…

Bristol-Myers Squibb Co (BMY) Industry Group Rank Penalize Rating

By Portfolio Grader

Bristol-Myers Squibb Co (NYSE:BMY) is a $103.5 billion in market value constituent of the Pharmaceuticals GICS industry group where Portfolio Grader’s current ranking for BMY…

Industry Group Rank Limit Bristol-Myers Squibb Co (BMY) Rating

By Portfolio Grader

The current recommendation of Hold for Bristol-Myers Squibb Co (NYSE:BMY) has been derived by using Louis Navellier’s methodology for investing and his Portfolio Grader stock…

Bristol-Myers Squibb Co (BMY) Earnings Growth Penalize Rating

By Portfolio Grader

The current recommendation of Hold for Bristol-Myers Squibb Co (NYSE:BMY) is derived using the methodology of Louis Navellier for investing and his Portfolio Grader stock…

Anemic Quant Score Restrict Bristol-Myers Squibb Co (BMY) Rating

By Portfolio Grader

Bristol-Myers Squibb Co (NYSE:BMY) is ranked as a Hold using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. This represents…

4 – 10 of 240 results